TY - JOUR
T1 - Copper regulates cyclic-AMP-dependent lipolysis
AU - Krishnamoorthy, Lakshmi
AU - Cotruvo, Joseph A.
AU - Chan, Jefferson
AU - Kaluarachchi, Harini
AU - Muchenditsi, Abigael
AU - Pendyala, Venkata S.
AU - Jia, Shang
AU - Aron, Allegra T.
AU - Ackerman, Cheri M.
AU - Wal, Mark N.Vander
AU - Guan, Timothy
AU - Smaga, Lukas P.
AU - Farhi, Samouil L.
AU - New, Elizabeth J.
AU - Lutsenko, Svetlana
AU - Chang, Christopher J.
N1 - Publisher Copyright:
© 2016 Nature America, Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Cell signaling relies extensively on dynamic pools of redox-inactive metal ions such as sodium, potassium, calcium and zinc, but their redox-Active transition metal counterparts such as copper and iron have been studied primarily as static enzyme cofactors. Here we report that copper is an endogenous regulator of lipolysis, the breakdown of fat, which is an essential process in maintaining body weight and energy stores. Using a mouse model of genetic copper misregulation, in combination with pharmacological alterations in copper status and imaging studies in a 3T3-L1 white adipocyte model, we found that copper regulates lipolysis at the level of the second messenger, cyclic AMP (cAMP), by altering the activity of the cAMP-degrading phosphodiesterase PDE3B. Biochemical studies of the copper-PDE3B interaction establish copper-dependent inhibition of enzyme activity and identify a key conserved cysteine residue in a PDE3-specific loop that is essential for the observed copper-dependent lipolytic phenotype.
AB - Cell signaling relies extensively on dynamic pools of redox-inactive metal ions such as sodium, potassium, calcium and zinc, but their redox-Active transition metal counterparts such as copper and iron have been studied primarily as static enzyme cofactors. Here we report that copper is an endogenous regulator of lipolysis, the breakdown of fat, which is an essential process in maintaining body weight and energy stores. Using a mouse model of genetic copper misregulation, in combination with pharmacological alterations in copper status and imaging studies in a 3T3-L1 white adipocyte model, we found that copper regulates lipolysis at the level of the second messenger, cyclic AMP (cAMP), by altering the activity of the cAMP-degrading phosphodiesterase PDE3B. Biochemical studies of the copper-PDE3B interaction establish copper-dependent inhibition of enzyme activity and identify a key conserved cysteine residue in a PDE3-specific loop that is essential for the observed copper-dependent lipolytic phenotype.
UR - http://www.scopus.com/inward/record.url?scp=84976274777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84976274777&partnerID=8YFLogxK
U2 - 10.1038/nchembio.2098
DO - 10.1038/nchembio.2098
M3 - Article
C2 - 27272565
AN - SCOPUS:84976274777
SN - 1552-4450
VL - 12
SP - 586
EP - 592
JO - Nature chemical biology
JF - Nature chemical biology
IS - 8
ER -